Table 4 Outcomes for propensity-matched patients
Variable | Overall (n = 628) | Control group (n = 314) | Treatment group (n = 314) | p value |
|---|---|---|---|---|
Primary outcome | 170 (27.1) | 79 (25.2) | 91 (29.0) | 0.281 |
 In-hospital mortality | 129 (20.5) | 60 (19.1) | 69 (22.0) | 0.374 |
 RRT dependence | 22 (3.5) | 13 (4.1) | 9 (2.9) | 0.385 |
 No AKI recovery | 93 (14.8) | 42 (13.4) | 51 (16.2) | 0.312 |
AKI max-urine output | Â | Â | Â | 0.123 |
 No AKI | 120 (19.1) | 66 (21.0) | 54 (17.2) |  |
 Stage 1 | 202 (32.2) | 110 (35.0) | 92 (29.3) |  |
 Stage 2 | 212 (33.8) | 95 (30.3) | 117 (37.3) |  |
 Stage 3 | 94 (15.0) | 43 (13.7) | 51 (16.2) |  |
AKI max-creatinine |  |  |  | < 0.001 |
 No AKI | 186 (29.6) | 135 (43.0) | 51 (16.2) |  |
 Stage 1 | 213 (33.9) | 92 (29.3) | 121 (38.5) |  |
 Stage 2 | 89 (14.2) | 31 (9.9) | 58 (18.5) |  |
 Stage 3 | 140 (22.3) | 56 (17.8) | 84 (26.8) |  |
AKI max |  |  |  | < 0.001 |
 Stage 1 | 236 (37.6) | 142 (45.2) | 94 (29.9) |  |
 Stage 2 | 225 (35.8) | 105 (33.4) | 120 (38.2) |  |
 Stage 3 | 167 (26.6) | 67 (21.3) | 100 (31.8) |  |
RRT during ICU stay | 96 (15.3) | 44 (14.0) | 52 (16.6) | 0.375 |
ICU LOS (days) | 3.8 (2.3–6.9) | 2.7 (1.7–4.8) | 5.6 (3.7–9.6) | < 0.001 |
ICU mortality | 58 (9.2) | 25 (8.0) | 33 (10.5) | 0.27 |
Hospital LOS (days) | 40 (23–69) | 35 (21–62) | 44 (26–76) | 0.001 |
Dialysis-free survival | 482 (76.8) | 243 (77.4) | 239 (76.1) | 0.706 |